TNF and rheumatoid arthritis: As shown in Figure 3, a similar allele dose-dependent trend towards an association of c.665C>T genotypes with the therapy response was observed among the RA cases treated with anti-TNF-α monoclonal antibody (mAb) drugs and in cases treated with an anti-TNF-α fusion protein (FP).